Učitavanje...
Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review
With a median age of 72 years at first diagnosis, chronic lymphocytic leukaemia (CLL) is a disease of the elderly. At this age, many patients cannot bear an intensive chemoimmunotherapy like fludarabine, cyclophosphamide and rituximab (FCR), and therapeutic decisions are commonly complicated by a hi...
Spremljeno u:
| Izdano u: | Ther Adv Hematol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5424860/ https://ncbi.nlm.nih.gov/pubmed/28567239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620717699365 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|